|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides compositions and methods for treating cancer.
|
|
gptkbp:applicationNumber
|
10/703,052
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,101,706_B2
gptkb:US_7,211,267_B2
gptkb:US_7,276,440_B2
gptkb:US_7,300,970_B2
US_7,332,200_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:contains
|
active pharmaceutical ingredient
|
|
gptkbp:examiner
|
gptkb:John_Doe
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingDate
|
March 29, 2004
|
|
gptkbp:grantDate
|
September 14, 2004
|
|
gptkbp:hasActivities
|
anti-cancer activity
|
|
gptkbp:hasFilm
|
anemia
fatigue
nausea
hair loss
increased risk of infection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,449 C8
|
|
gptkbp:internationalClassification
|
A61K 31/00
C07D 401/12
|
|
gptkbp:inventor
|
gptkb:Robert_A._McCormick
|
|
gptkbp:isAttendedBy
|
gptkb:FDA
|
|
gptkbp:isMarketedAs
|
gptkb:Avastin
Erbitux
Tarceva
Carboplatin
Docetaxel
Doxorubicin
Cisplatin
Gemzar
Paclitaxel
Taxotere
Xeloda
|
|
gptkbp:isPartOf
|
cancer treatment regimen
|
|
gptkbp:issuedOn
|
September 14, 2004
|
|
gptkbp:isUsedIn
|
combination therapy
chemotherapy
targeted therapy
|
|
gptkbp:isVisitedBy
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:legalStatus
|
patent granted
|
|
gptkbp:priorityDate
|
March 29, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,800,300_B2
US_6,787,550_B2
US_6,787,551_B2
US_6,787,552_B2
US_6,787,553_B2
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Compositions and methods for treating cancer
|